ClinicalTrials.gg
CompletedNCT05108103Updated Oct 3, 2022

Determination of Longus Colli Muscle Thickness by Ultrasonography

An observational study in Pain Syndrome, Pain, Intractable and Complex Regional Pain Syndromes, sponsored by Istanbul University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-03.

Sponsored by Istanbul University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to assess the longus colli muscle thickness by ultrasonography in order to guide stellate ganglion blocks

Read the detailed description

Stellate ganglion block is an interventional pain management procedure that is often performed for diagnostic and therapeutic purposes. It has long been performed with the guidance of fluoroscopy, and despite the increasing use of ultrasonography in recent years, fluoroscopy is still the gold standard method.

In traditional fluoroscopic method, the needle is directed to the transverse process of the C6 vertebra, after touching the anterior tubercle (Chassaignac's tubercule) the needle is slightly withdrawn and following a negative aspiration, injection is performed.

The ideal placement of the needle should be anterolateral to the longus colli muscle and deep to the prevertebral fascia. Further placement may cause intramuscular spread and superficial placement may cause injection in the carotid sheath or vascular structures. These are the most important reasons for clinical ineffectiveness. How far should the needle be withdrawn? Data is inconsistent in the literature.

The primary aim of this study is to determine the distance from transverse process to longus colli muscles anterior border and from transverse process to carotid sheath's posterior border. Secondary aim is to investigate the relationship between longus colli muscle thickness and age, gender, height, weight, BMI and neck circumference.

02

Conditions studied

  • Pain Syndrome
  • Pain, Intractable
  • Complex Regional Pain Syndromes
  • Hyperhidrosis

Keywords

  • Stellate Ganglion
  • Longus Colli Muscle
  • Ultrasound
03

In context

Somatoform Disorders

405 studies on the registry are indexed under Somatoform Disorders; 79 are open to participants now.

This study's enrollment of 200 is above the median of 96 across 78 observational studies indexed under Somatoform Disorders.

Browse Somatoform Disorders studies →

Lead sponsor

Istanbul University is the lead sponsor of 507 studies on the registry; 80 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy volunteers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 - 65 years,
  • Giving informed consent for examination, ultrasonographic evaluation and study participation

Exclusion criteria

Exclusion Criteria:

  • Having a chronic neck pain for more than 6 months,
  • Having any neurological or musculoskeletal conditions that may affect the anatomy of cervical region (cervical disc herniation, torticollis, severe scoliosis, vertebral malformation, spinal stenosis, myopathies, etc.)
  • Having a history of surgery or radiation therapy in the cervical region
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Distance between corpus and longus colli muscle's anterior border on C6 level (millimeters)

    Distance between corpus and longus colli muscle's anterior border on C6 level will be evaluated with ultrasonography.

    Time frame: 0 minutes

Secondary outcomes

  1. Distance between corpus and longus colli muscle's anterior border on C7 level (millimeters)

    Distance between corpus and longus colli muscle's anterior border on C7 level will be evaluated with ultrasonography.

    Time frame: 0 minutes

  2. Maximum anteroposterior width of longus colli muscle on C6 level (millimeters)

    Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.

    Time frame: 0 minutes

  3. Maximum anteroposterior width of longus colli muscle on C7 level (millimeters)

    Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.

    Time frame: 0 minutes

  4. Distance between esophagus and estimated needle plane (millimeters)

    Distance between esophagus and estimated needle plane will be evaluated with ultrasonography.

    Time frame: 0 minutes

  5. Neck circumference (centimeters)

    Neck circumference

    Time frame: 0 minutes

07

Study locations

1 site
  • Halil Çetingök
    Istanbul, 34093, Turkey (Türkiye)
08

References and documents

Publications

  • Ates Y, Asik I, Ozgencil E, Acar HI, Yagmurlu B, Tekdemir I. Evaluation of the longus colli muscle in relation to stellate ganglion block. Reg Anesth Pain Med. 2009 May-Jun;34(3):219-23. doi: 10.1097/AAP.0b013e3181a32a02. PubMed 19436184 ↗
  • Narouze S. Ultrasound-guided stellate ganglion block: safety and efficacy. Curr Pain Headache Rep. 2014 Jun;18(6):424. doi: 10.1007/s11916-014-0424-5. PubMed 24760493 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2021 to primary completion in Mar 2022, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2021
First posted
Nov 4, 2021
StartActual
Mar 1, 2021
Primary completionActual
Mar 1, 2022
CompletionActual
Jun 1, 2022
Last update
Oct 3, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05108103
Responsible party
Halil Cetingok (Assistant Professor, Istanbul University) — Principal investigator
First posted
Nov 4, 2021
Start date
Mar 1, 2021
Primary completion
Mar 1, 2022
Completion
Jun 1, 2022
Last update
Oct 3, 2022

Study contacts

Halil Çetingök, Ass. Prof.
principal investigator · Istanbul University Istanbul Faculty of Medicine, Department of Pain Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion